Clinical Trial

Minipuberty in Infants Born With Potential Hypogonadism Hypogonadotrope

Study acronym: MiniNO
Recruiting
View on ClinicalTrials.gov →
Summary
Disorders of sex development (DSD) occur in 1/3000 births and are defined by variation in aspect of external genital organs, e.g. cryptorchidism, hypospadias and micropenis in male infants and clitoral hypertrophy in female infants. Genetic, hormonal and environmental factors are implicated in DSD. Infants with congenital hypogonadism hypogonadotrope (CHH) can present with DSD. Evaluation of hormonal profile during minipuberty could be of great help to better characterize the etiology of DSD and CHH in particular. Our main objective is to study hormonal profile during the minipuberty of infants born with DSD or born from parents with CHH compared to controls.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-09-17.
Trial Details
NCT Number NCT05058781
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Conditions DSD, CHH
Enrollment 100 participants
Start Date 2017-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-07-22